• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

澳大利亚南部幽门螺杆菌感染的地理空间分析:地理位置是否会影响根除治疗?

Geospatial analysis of Helicobacter pylori infection in South Australia: Should location influence eradication therapy?

机构信息

Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, South Australia, Australia.

Department of Gastroenterology, The Queen Elizabeth Hospital, Adelaide, South Australia, Australia.

出版信息

J Gastroenterol Hepatol. 2022 Jul;37(7):1263-1274. doi: 10.1111/jgh.15832. Epub 2022 Mar 31.

DOI:10.1111/jgh.15832
PMID:35315547
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9543722/
Abstract

BACKGROUND AND AIM

Rates of antimicrobial-resistant Helicobacter pylori infection are rising globally; however, geospatial location and its interaction with risk factors for infection have not been closely examined.

METHODS

Gastric biopsy specimens were collected to detect H. pylori infection at multiple centers in Adelaide, South Australia, between 1998 and 2017. The geospatial distribution of antibiotic-resistant H. pylori in the Greater Adelaide region was plotted using choropleth maps. Moran's I was used to assess geospatial correlation, and multivariate linear regression (MLR) was used to examine associations between migration status, socioeconomic status, age, gender, and rates of H. pylori positivity and antibiotic resistance. Geographically weighted regression (GWR) was used to determine the extent to which the associations varied according to geospatial location.

RESULTS

Of 20 108 biopsies across 136 postcodes within the Greater Adelaide region, 1901 (9.45%) were H. pylori positive. Of these, 797 (41.9%) displayed clarithromycin, tetracycline, metronidazole, or amoxicillin resistance. In MLR, migration status was associated with the rate of H. pylori positivity (β = 3.85% per 10% increase in a postcode's migrant population; P < 0.001). H. pylori positivity and resistance to any antibiotic were geospatially clustered (Moran's I = 0.571 and 0.280, respectively; P < 0.001 for both). In GWR, there was significant geospatial variation in the strength of the migrant association for both H. pylori positivity and antibiotic resistance.

CONCLUSION

Our study demonstrates the heterogeneous geospatial distribution of H. pylori positivity and antibiotic resistance, as well as its interaction with migrant status. Geographic location and migrant status are important factors to consider for H. pylori eradication therapy.

摘要

背景与目的

全球范围内,对抗生素耐药的幽门螺杆菌(Helicobacter pylori)感染率正在上升;然而,其地理空间位置及其与感染风险因素的相互作用尚未得到密切研究。

方法

1998 年至 2017 年间,在南澳大利亚阿德莱德的多个中心采集胃活检标本,以检测 H. pylori 感染。使用面域图绘制阿德莱德大都市区抗生素耐药性 H. pylori 的地理空间分布。使用 Moran's I 评估地理空间相关性,并用多元线性回归(MLR)分析移民状况、社会经济地位、年龄、性别以及 H. pylori 阳性率和抗生素耐药率之间的关系。使用地理加权回归(GWR)确定关联随地理空间位置变化的程度。

结果

在阿德莱德大都市区的 136 个邮区中的 20108 个活检中,1901 个(9.45%)为 H. pylori 阳性。其中,797 个(41.9%)显示克拉霉素、四环素、甲硝唑或阿莫西林耐药。在 MLR 中,移民状况与 H. pylori 阳性率相关(每 10%增加一个邮区的移民人口,阳性率增加 3.85%;P < 0.001)。H. pylori 阳性和对任何抗生素的耐药性呈地理空间聚类(Moran's I 分别为 0.571 和 0.280;两者均 P < 0.001)。在 GWR 中,H. pylori 阳性和抗生素耐药性的移民相关性存在显著的地理空间差异。

结论

本研究表明,H. pylori 阳性和抗生素耐药性具有异质的地理空间分布,以及其与移民状况的相互作用。地理位置和移民状况是根除 H. pylori 治疗的重要考虑因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3ef/9543722/e6528dead2be/JGH-37-1263-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3ef/9543722/b6ecfa8fd5e5/JGH-37-1263-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3ef/9543722/a045eeda04a8/JGH-37-1263-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3ef/9543722/14d58c5812a7/JGH-37-1263-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3ef/9543722/8c47ffabe0a2/JGH-37-1263-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3ef/9543722/aec410748715/JGH-37-1263-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3ef/9543722/bd70795fb6c2/JGH-37-1263-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3ef/9543722/94d19450dcb8/JGH-37-1263-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3ef/9543722/f37d42a7b67a/JGH-37-1263-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3ef/9543722/e6528dead2be/JGH-37-1263-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3ef/9543722/b6ecfa8fd5e5/JGH-37-1263-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3ef/9543722/a045eeda04a8/JGH-37-1263-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3ef/9543722/14d58c5812a7/JGH-37-1263-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3ef/9543722/8c47ffabe0a2/JGH-37-1263-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3ef/9543722/aec410748715/JGH-37-1263-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3ef/9543722/bd70795fb6c2/JGH-37-1263-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3ef/9543722/94d19450dcb8/JGH-37-1263-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3ef/9543722/f37d42a7b67a/JGH-37-1263-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3ef/9543722/e6528dead2be/JGH-37-1263-g004.jpg

相似文献

1
Geospatial analysis of Helicobacter pylori infection in South Australia: Should location influence eradication therapy?澳大利亚南部幽门螺杆菌感染的地理空间分析:地理位置是否会影响根除治疗?
J Gastroenterol Hepatol. 2022 Jul;37(7):1263-1274. doi: 10.1111/jgh.15832. Epub 2022 Mar 31.
2
Increasing Helicobacter pylori clarithromycin resistance in Australia over 20 years.澳大利亚 20 多年来幽门螺杆菌克拉霉素耐药率不断上升。
Intern Med J. 2022 Sep;52(9):1554-1560. doi: 10.1111/imj.15640. Epub 2022 Aug 19.
3
The effect of previous eradication failure on antibiotic resistance of Helicobacter pylori: A retrospective study over 8 years in Beijing.既往根除失败对幽门螺杆菌耐药性的影响:北京 8 年回顾性研究。
Helicobacter. 2021 Aug;26(4):e12804. doi: 10.1111/hel.12804. Epub 2021 Apr 16.
4
High incidence of antibiotic resistance amongst isolates of collected in Nottingham, UK, between 2001 and 2018.2001 年至 2018 年间,在英国诺丁汉收集的分离物中,抗生素耐药率很高。
J Med Microbiol. 2023 Nov;72(11). doi: 10.1099/jmm.0.001776.
5
Helicobacter pylori resistance to antibiotics before and after treatment: Incidence of eradication failure.治疗前后幽门螺杆菌对抗生素的耐药性:根除失败的发生率。
PLoS One. 2022 Apr 20;17(4):e0265322. doi: 10.1371/journal.pone.0265322. eCollection 2022.
6
Characteristics of phenotypic antibiotic resistance of Helicobacter pylori and its correlation with genotypic antibiotic resistance: A retrospective study in Ningxia.宁夏地区幽门螺杆菌表型耐药特征及其与基因型耐药的相关性:一项回顾性研究。
Helicobacter. 2023 Jun;28(3):e12960. doi: 10.1111/hel.12960. Epub 2023 Apr 11.
7
Primary Antibiotic Resistance And Effectiveness Of Clarithromycin Vs Metronidazole Based Therapy For Helicobacter Pylori Infection In Children.儿童幽门螺杆菌感染中克拉霉素与甲硝唑为基础的治疗方案的原发性抗生素耐药性和有效性。
J Ayub Med Coll Abbottabad. 2023 Jul-Sep;35(3):390-393. doi: 10.55519/JAMC-03-11648.
8
Antibiotic resistance patterns and therapeutic outcomes of pediatric Helicobacter pylori infection in a high-migrant Singaporean cohort.在新加坡高移民人群中,儿童幽门螺杆菌感染的抗生素耐药模式和治疗结果。
Helicobacter. 2022 Feb;27(1):e12868. doi: 10.1111/hel.12868. Epub 2021 Dec 27.
9
Antimicrobial susceptibility of clinical isolates and its eradication by standard triple therapy: a study in west central region of Colombia.临床分离株的抗菌药敏性及其标准三联疗法的根除效果:哥伦比亚中西部地区的一项研究。
Microbiol Spectr. 2024 Aug 6;12(8):e0040124. doi: 10.1128/spectrum.00401-24. Epub 2024 Jun 25.
10
Increasing antimicrobial resistance to clarithromycin and metronidazole in pediatric Helicobacter pylori infection in southern Taiwan: A comparison between two decades.台湾南部儿童幽门螺杆菌感染中克拉霉素和甲硝唑耐药性的增加:二十年的对比。
Helicobacter. 2019 Oct;24(5):e12633. doi: 10.1111/hel.12633. Epub 2019 Jul 11.

引用本文的文献

1
Sustain-release lipid-liquid crystal formulations of pexiganan against Helicobacter pylori infection: in vitro evaluation in C57BL/6 mice.pexiganan 缓释脂-液晶制剂抗幽门螺杆菌感染的研究:C57BL/6 小鼠体内评价。
BMC Pharmacol Toxicol. 2024 Jan 11;25(1):9. doi: 10.1186/s40360-024-00731-z.
2
Epidemiology of Resistance to Antibiotics (A Narrative Review).抗生素耐药性的流行病学(一篇叙述性综述)
Antibiotics (Basel). 2023 Jul 13;12(7):1184. doi: 10.3390/antibiotics12071184.
3
Mutations Associated to Antibiotic-Resistant : It Is Time to Validate Sequencing Observations.

本文引用的文献

1
Antibiotic resistance of Helicobacter pylori in Australia and New Zealand: A systematic review and meta-analysis.澳大利亚和新西兰幽门螺杆菌的抗生素耐药性:系统评价和荟萃分析。
J Gastroenterol Hepatol. 2021 Jun;36(6):1450-1456. doi: 10.1111/jgh.15352. Epub 2021 Jan 3.
2
eradication therapy to prevent gastric cancer: systematic review and meta-analysis.根除疗法预防胃癌:系统评价和荟萃分析。
Gut. 2020 Dec;69(12):2113-2121. doi: 10.1136/gutjnl-2020-320839. Epub 2020 Mar 23.
3
Is the Utilization of Helicobacter pylori Stool Antigen Tests Appropriate in an Urban Canadian Population?
与抗生素耐药性相关的突变:是时候验证测序观察结果了。
J Clin Med. 2022 Jul 24;11(15):4293. doi: 10.3390/jcm11154293.
在加拿大城市人群中,是否适宜使用幽门螺杆菌粪便抗原检测?
Am J Clin Pathol. 2020 Apr 15;153(5):686-694. doi: 10.1093/ajcp/aqz210.
4
Geospatial analyses identify regional hot spots of diffuse gastric cancer in rural Central America.地理空间分析确定中美洲农村地区弥漫性胃癌的区域热点。
BMC Cancer. 2019 Jun 7;19(1):545. doi: 10.1186/s12885-019-5726-x.
5
Guidelines for the management of Helicobacter pylori infection in Japan: 2016 Revised Edition.日本幽门螺杆菌感染管理指南:2016 年修订版。
Helicobacter. 2019 Aug;24(4):e12597. doi: 10.1111/hel.12597. Epub 2019 May 20.
6
Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions.幽门螺杆菌抗生素耐药性的流行情况:世界卫生组织区域的系统评价和荟萃分析。
Gastroenterology. 2018 Nov;155(5):1372-1382.e17. doi: 10.1053/j.gastro.2018.07.007. Epub 2018 Jul 7.
7
Primary antibiotic resistance in Helicobacter pylori in the Asia-Pacific region: a systematic review and meta-analysis.亚太地区幽门螺杆菌的主要抗生素耐药性:系统评价和荟萃分析。
Lancet Gastroenterol Hepatol. 2017 Oct;2(10):707-715. doi: 10.1016/S2468-1253(17)30219-4. Epub 2017 Aug 7.
8
A systematic review and meta-analysis of the role of eradication in preventing gastric cancer.根除幽门螺杆菌在预防胃癌中作用的系统评价与荟萃分析 (注:原文中未明确“eradication”具体所指,根据医学常识推测可能是“幽门螺杆菌根除”,完整准确的翻译需结合更多上下文信息)
Ann Gastroenterol. 2017;30(4):414-423. doi: 10.20524/aog.2017.0144. Epub 2017 Apr 7.
9
Epidemiology, clinical impacts and current clinical management of Helicobacter pylori infection.幽门螺杆菌感染的流行病学、临床影响和当前临床管理。
Med J Aust. 2016 Jun 6;204(10):376-80. doi: 10.5694/mja16.00104.
10
Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis.幽门螺杆菌根除与胃癌发病率的关系:系统评价和荟萃分析。
Gastroenterology. 2016 May;150(5):1113-1124.e5. doi: 10.1053/j.gastro.2016.01.028. Epub 2016 Feb 2.